Suzhou Highfine Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Suzhou Highfine Biotech has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥82.7M respectively. Suzhou Highfine Biotech's EBIT is CN¥58.9M making its interest coverage ratio -1.1. It has cash and short-term investments of CN¥1.7B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.1x |
| Cash | CN¥1.73b |
| Equity | CN¥2.22b |
| Total liabilities | CN¥82.66m |
| Total assets | CN¥2.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301393's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥73.5M).
Long Term Liabilities: 301393's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥9.1M).
Debt to Equity History and Analysis
Debt Level: 301393 is debt free.
Reducing Debt: 301393 had no debt 5 years ago.
Debt Coverage: 301393 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301393 has no debt, therefore coverage of interest payments is not a concern.